Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
29 April 2024 - O0812
Dalbavancin is non-inferior to standard-of-care therapy for complicated Staphylococcus aureus bacteraemia (SAB)
Nicholas Turner, Toshimitsu Hamasaki, Scott Evans, Sarah Doernberg, Thomas Lodise, Heather King, Varduhi Ghazaryan, Sara Cosgrove, Timothy Jenkins, Catherine Liu, Shrabani Sharma, Smitha Zaharoff, Lana Wahid, Paul Cook, Issam Raad, Ray Hachem, Anne-Marie Chaftari, Matthew Sims, Carmen Demarco, Loren Miller, Matthew Mccarthy, Caryn Morse, Chris Lucasti, Graeme Forrest, Kartikeya Cherabuddi, Christopher Polk, Tasaduq Fazili, Marcus Rupp, George Thompson, Kami Kim, Luke Strnad, Amanda Schnee, James Mckinnell, Mayur Ramesh, Fernanda Silveira, Todd Mccarty, Todd Lee, Emily Mcdonald, Kristopher Paolino, Katie Wiegand, Alison Wall, Todd Riccobene, Rinal Patel, Urania Rappo, Henry Chambers, Vance Fowler, Thomas Holland
28 April 2024 - P2542
Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multi-drug resistant Pseudomonas aeruginosa
Thomas Lodise, Engels Obi, Alexandre Watanabe, Jae Min, Brian Nathanson, Emre Yucel
28 April 2024 - P2461
In vivo efficacy of humanized pulmonary exposures of WCK 5222 (cefepime/zidebactam) in neutropenic murine lung infection caused by carbapenemase-producing Klebsiella pneumoniae (KP) and Acinetobacter baumannii (AB) with WCK 5222
Thomas Lodise, Anouk Edwina Muller, , Kushal Umarkar, Swapna Takalkar, Rajesh Chavan, Hariharan Periasamy, Sachin Bhagwat, Mahesh Patel
28 April 2024 - P2419
Pharmacokinetics and safety in ICU patients and healthy participants following single dose administration of zosurabalpin (RG6006), a novel pathogen-specific antibiotic for the treatment of serious Acinetobacter infections
Emmanuelle Cottreel, Bruno François, Akram Khan, Andreas Günther, Amanda Messer, Laurie Millar, Katie Patel, Lu Yuan, Thomas Lodise, Michael Lobritz
28 April 2024 - P2297
In vitro activity of cefepime/zidebactam (WCK 5222) against a panel of MDR/XDR Pseudomonas aeruginosa isolates from India enriched with resistance to novel β-lactam/ β-lactamase inhibitor combinations
Thomas Lodise, Anouk Edwina Muller, Yamuna Devi Bakthavatchalam, Prashant Joshi, Snehal Palwe, Mohammad Furkhan, Hariharan Periasamy, Balaji Veeraraghavan, Sachin Bhagwat, Mahesh Patel
17 April 2023 - P2106
In vitro microbiologic activity of WCK 4282 (high-dose cefepime/tazobactam combination) against OXA-1-harbouring, ESBL-phenotype E. coli and K. pneumoniae clinical isolates
Thomas Lodise, Yuvasri Manokaran, Yamuna Devi Bakthavachalam, Balaji Veeraraghavan, Anouk Edwina Muller
16 April 2023 - P1425
Epidemiology of Acinetobacter baumannii among adult patients across United States hospitals
Thomas Lodise, Sean Nguyen, Jennifer Copeland, Caroline Margiotta, Bin Cai
23 April 2022 - P0635
Relationship between receipt of prior antibiotics and presence of antibiotic resistance among adult outpatients with complicated urinary tract infections
Thomas Lodise, Rong Wei, Lie Chen, Richard Contreras, Theresa Im, Katia Bruxvoort, Mauricio Rodriguez, Larry Friedrich, Jennifer Reese, Sara Tartof
16 April 2019 - P2288
Incidence of emergency department visits and hospitalisations after outpatient treatment with an oral antibiotic among patients with acute bacterial skin and skin structure infections
Kenneth LaPensee, Hoa Le, Thomas Lodise
16 April 2019 - P2287
Iclaprim versus vancomycin for patients with acute bacterial skin and skin structure infection complicated by Staphylococcus aureus or streptococcal bacteraemia: a pooled analysis of the phase III REVIVE trials
Stephanie Noviello, Thomas Lodise, Thomas Holland, G. Ralph Corey, Lynda Berne, David Huang
15 April 2019 - P1930
Assessment of cloud-based Bayesian software to estimate vancomycin exposure in obese individuals with limited pharmacokinetic sampling
Joseph Carreno, Thomas Lodise
14 April 2019 - P0899
Relationship between delayed inappropriate therapy and number of resistant beta-lactam classes among hospitalised adult patients with pneumonia due to Pseudomonas aeruginosa
Thomas Lodise, Sara Tartof, Lie Chen, Rong Wei, Laura Puzniak, Yun Tian, Theresa Im, Thomas Lodise
13 April 2019 - P0467
Comparison of incidence of aortic aneurysm/dissection between hospitalised community-acquired pneumonia patients receiving either fluoroquinolone or ceftriaxone/azithromycin therapy
Nimish Patel, Allison Gorseth, Ronish Amin, Nicholas Stornelli, Breanna Pelski, Thomas Lodise
13 April 2019 - P0466
Comparison of incidence of adverse tendon events between fluoroquinolone and ceftriaxone/azithromycin recipients among hospitalised community-acquired pneumonia patients from 2011-2016
Nimish Patel, Gina Belfiore, Megan Haggerty, Courtney Ackerman, Jeffrey Clark, Colleen Lowry, Thomas Lodise
13 April 2019 - O0303
An efficacy analysis by lesion size of iclaprim versus vancomycin in patients with acute bacterial skin and skin structure infections: pooled phase III REVIVE trials
Stephanie Noviello, Mark H. Wilcox, Matthew Dryden, Thomas Holland, G. Ralph Corey, William D. O’Riordan, Thomas File, Antoni Torres, Thomas Lodise, Lynda Berne, David Huang
21 April 2018 - O0130
A clinical risk score to predict the likelihood of carbapenem non-susceptible and pan-beta-lactam non-susceptibility among adult, hospitalized patients with infections due to Pseudomonas aeruginosa
Thomas Lodise, S. Tartof, J. Kuntz, L. Chen, R. Wei, L. Puzniak, Y. Tian, T. Im, H. Takhar, S. Merchant, l. thomas
25 April 2017 - OS0991
Relationship between antibiotic treatment failure and 30-Day mortality in adult outpatients with community-acquired pneumonia
Filippo Del Puente, Donna Mildvan, Thomas Lodise, Antonio Lepore, Peter Classi, Glenn Tillotson
25 April 2017 - OS0993
Adverse events associated with fluoroquinolone and macrolide therapy in adult outpatients treated for community-acquired pneumonia
Filippo Del Puente, Thomas Lodise, Donna Mildvan, Antonio Lepore, Peter Classi, Glenn Tillotson
24 April 2017 - P1266
Cost-saving opportunities among hospitalized patients with acute bacterial skin and skin structure infections with omadacycline, a once-daily antibiotic with IV-to-oral transition capability, relative to current standard of inpatient care
Alison Freifeld, Kenneth LaPensee, Thomas Lodise
24 April 2017 - P1265
Economic impact of omadacycline among acute bacterial skin and skin structure infections (ABSSSIs) patients: cost-saving opportunities due to avoidable hospitalizations using an antibiotic with IV-to-oral switch capability
Alison Freifeld, Kenneth LaPensee, Thomas Lodise
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.